Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis

被引:191
作者
Becker, Christoph
Dornhoff, Heike
Neufert, Clemens
Fantini, Massimo C.
Wirtz, Stefan
Huebner, Sabine
Nikolaev, Alexei
Lehr, Hans-Anton
Murphy, Andrew J.
Valenzuela, David M.
Yancopoulos, George D.
Galle, Peter R.
Karow, Margaret
Neurath, Markus F.
机构
[1] Johannes Gutenberg Univ Mainz, Med Clin 1, Immunol Lab, D-55101 Mainz, Germany
[2] Univ Lausanne, Inst Pathol, CH-1015 Lausanne, Switzerland
[3] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
10.4049/jimmunol.177.5.2760
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although IL-12 and IL-23 share the common p40 subunit, IL-23, rather than IL-12, seems to drive the pathogenesis of experimental autoimmune encephalomyelitis and arthritis, because IL-23/p19 knockout mice are protected from disease. In contrast, we describe in this study that newly created LacZ knockin mice deficient for IL-23 p19 were highly susceptible for the development of experimental T cell-mediated TNBS colitis and showed even more severe colitis than wild-type mice by endoscopic and histologic criteria. Subsequent studies revealed that dendritic cells from p19-deficient mice produce elevated levels of IL-12, and that IL-23 down-regulates IL-12 expression upon TLR ligation. Finally, in vivo blockade of IL-12p40 in IL-23-deficient mice rescued mice from lethal colitis. Taken together, our data identify cross-regulation of IL-12 expression by IL-23 as novel key regulatory pathway during initiation of T cell dependent colitis.
引用
收藏
页码:2760 / 2764
页数:5
相关论文
共 20 条
[1]   Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells [J].
Becker, C ;
Wirtz, S ;
Blessing, M ;
Pirhonen, J ;
Strand, D ;
Bechthold, O ;
Frick, J ;
Galle, PR ;
Autenrieth, I ;
Neurath, MF .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) :693-706
[2]   The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[3]   Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[4]  
Davidson NJ, 1998, J IMMUNOL, V161, P3143
[5]   Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota [J].
Elson, CO ;
Cong, Y ;
McCracken, VJ ;
Dimmitt, RA ;
Lorenz, RG ;
Weaver, CT .
IMMUNOLOGICAL REVIEWS, 2005, 206 :260-276
[6]   Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis [J].
Fantini, MC ;
Becker, C ;
Tubbe, I ;
Nikolaev, A ;
Lehr, HA ;
Galle, P ;
Neurath, MF .
GUT, 2006, 55 (05) :671-680
[7]   Cutting edge:: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+ CD25+ T cells [J].
Huber, S ;
Schramm, C ;
Lehr, HA ;
Mann, A ;
Schmitt, S ;
Becker, C ;
Protschka, M ;
Galle, PR ;
Neurath, MF ;
Blessing, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (11) :6526-6531
[8]   New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions [J].
Hunter, CA .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (07) :521-531
[9]   Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria [J].
Kamada, N ;
Hisamatsu, T ;
Okamoto, S ;
Sato, T ;
Matsuoka, K ;
Arai, K ;
Nakai, T ;
Hasegawa, A ;
Inoue, N ;
Watanabe, N ;
Akagawa, KS ;
Hibi, T .
JOURNAL OF IMMUNOLOGY, 2005, 175 (10) :6900-6908
[10]   IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available [J].
Khader, SA ;
Pearl, JE ;
Sakamoto, K ;
Gilmartin, L ;
Bell, GK ;
Jelley-Gibbs, DM ;
Ghilardi, N ;
deSauvage, F ;
Cooper, AM .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :788-795